Advances in technology have significantly enhanced the tunability of cancer treatments. Techniques like Next-Generation Sequencing (NGS) allow for comprehensive genetic profiling, while CRISPR technology enables precise genetic editing. Artificial Intelligence (AI) and machine learning algorithms can analyze vast amounts of data to identify optimal treatment strategies for individual patients.
